Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study

Respiratory Research

Table 2 Comparison of patients in France undergoing pulmonary rehabilitation or not after severe acute exacerbation, according to French national health insurance database (SNDS, “Système National De Santé”)

	No pulmonary rehabilitation		Pulmonary rehabilitation		p-value
	N (%)	%	N (%)	%
	44,456	914	4182	8.6
Gender
Male	27,286	61.4	2243	53.6	< 0.0001
Age (years)
Mean (± SD)	73.3 ± 12.2		75.5 ± 11.6		< 0.0001
6 months mortality
Death	3278	7.4	525	12.6	< 0.0001
Healthcare coverage
French Free Universal Health Care/CMU	2370	5.3	151	3.6	< 0.0001
French Deprivation Index
Q1	5757	13.3	633	15.4	< 0.0001
Q2	7106	16.4	723	17.6
Q3	8744	20.2	891	21.7
Q4	9886	22.9	941	22.9
Q5	11,724	27.1	927	22.5
Non-invasive ventilation in 2017	1475	3.3	233	5.6	< 0.0001
Oxygen therapy in 2017	5812	13.1	761	18.2	< 0.0001
Rehabilitation care in year preceding hospitalization
Yes	12,937	29.1	1937	46.3	< 0.0001
Long-acting bronchodilator prescription in 2017
0	8726	19.6	749	17.9	0.0471
1	2685	6.0	238	5.7
2	1875	4.2	174	4.2
3	1690	3.8	154	3.7
≥ 4	29,480	66.3	2867	68.6
At least one long-term disease (ALD) in 2017
Presence	36,439	82.0	3616	86.5	< 0.0001
Type of ALD
Cardiovascular disease	19,594	44.1	1738	41.6	0.002
Respiratory disease	16,646	37.4	2207	52.8	< 0.0001
Metabolic disease	8690	19.6	649	15.5	< 0.0001
Tumor	6901	15.5	667	16.0	0.48
Charlson Index—5 principal components
Chronic lung disease	34,121	76.8	3581	85.6	< 0.0001
Disease of circulatory system	14,388	32.4	1385	33.1	0.32
Diabete	10,057	22.6	785	18.8	< 0.0001
Cancer	6755	15.2	657	15.7	0.38
Renal disease	3228	7.3	233	5.6	< 0.0001

CMU: Couverture Médicale Universelle, ALD: affection de longue durée, COPD: Chronic Obstructive Pulmonary Disease, SD: Standard Deviation

ISSN: 1465-993X